Gene · 6900
Papers4,207
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,207
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted antibody therapy as a treatment strategy for aggressive adult T-cell leukemia/lymphoma. | Leuk Res | 2025 | 39827571 | PubTator, text mining | PubMed |
| Development of machine learning models for diagnostic biomarker identification and immune cell infiltration analysis in PCOS. | J Ovarian Res | 2025 | 39754246 | PubTator, text mining | PubMed |
| Cryo-EM structures of the full-length human contactin-2. | FEBS J | 2025 | 39702996 | PubTator, text mining | PubMed |
| Retrograded starch as colonic delivery carrier of taxifolin for treatment of DSS-induced ulcerative colitis in mice. | Int J Biol Macromol | 2025 | 39672437 | PubTator, text mining | PubMed |
| Enhanced efficacy of quercetin and taxifolin encapsulated with pH-responsive injectable BSA hydrogel for targeting triple-negative breast cancer cells. | Int J Biol Macromol | 2025 | 39667444 | PubTator, text mining | PubMed |
| FUT8 Regulates Cerebellar Neurogenesis and Development Through Maintaining the Level of Neural Cell Adhesion Molecule Cntn2. | Mol Neurobiol | 2025 | 39604780 | PubTator, text mining | PubMed |
| Rewired chromatin structure and epigenetic gene dysregulation during HTLV-1 infection to leukemogenesis. | Cancer Sci | 2025 | 39561277 | PubTator, text mining | PubMed |
| Effect of Viral Antigen Mismatch on Antiviral T-Cell Response and Immunotherapeutic Efficacy Against Adult T-Cell Leukemia/Lymphoma. | J Infect Dis | 2025 | 39302694 | PubTator, text mining | PubMed |
| Leukemia-Related Signaling Pathways Among HTLV-1-Derived Adult T Cell Leukemia/Lymphoma and Asymptomatic Carriers in Comparison to Normal Group. | AIDS Res Hum Retroviruses | 2025 | 39003523 | PubTator, text mining | PubMed |
| Multi-task learning with multi-gate mixture of transformer-based experts for predictive process monitoring in manufacturing. | Sci Prog | 2024 | 39654299 | PubTator, text mining | PubMed |
| Novel genomic variants influencing methotrexate delayed clearance in pediatric patients with acute lymphoblastic leukemia. | Front Pharmacol | 2024 | 39611166 | PubTator, text mining | PubMed |
| An integrative study on the green cultural industry and its determinants in Jiangsu province, China under the cultural revitalization initiative: a global perspective. | Front Psychol | 2024 | 39606207 | PubTator, text mining | PubMed |
| A Novel Tax-Responsive Reporter T-Cell Line to Analyze Infection of HTLV-1. | Pathogens | 2024 | 39599568 | PubTator, text mining | PubMed |
| The impact of tax burden on welfare attitudes: Micro evidence from welfare states. | PLoS One | 2024 | 39556564 | PubTator, text mining | PubMed |
| Transactivation of the novel 5' cis-acting element of mouse mammary tumor virus (MMTV) by human retroviral transactivators Tat and Tax. | Commun Biol | 2024 | 39550519 | PubTator, text mining | PubMed |
| Antiviral immune response against HTLV-1 invalidates T-SPOT.TB® results in patients with HTLV-1-positive rheumatic diseases. | Front Immunol | 2024 | 39534598 | PubTator, text mining | PubMed |
| EZH2 Activates HTLV-1 bZIP Factor-Mediated TGF-β Signaling in Adult T-Cell Leukemia. | J Med Virol | 2024 | 39530290 | PubTator, text mining | PubMed |
| The role of CREB and MAPK signaling pathways in ATLL patients. | AIDS Res Ther | 2024 | 39529101 | PubTator, text mining | PubMed |
| Can changes in corporate income tax rate affect corporate innovation? | Heliyon | 2024 | 39474632 | PubTator, text mining | PubMed |
| Modeling and empirical evidence of the impact of implementation of sugar sweetened-beverages tax to reduce non-communicable diseases prevalence: a systematic review. | Front Nutr | 2024 | 39464684 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6900/papers?page=9